Author: Kouokam, Joseph Calvin; Lasnik, Amanda B.; Palmer, Kenneth E.
Title: Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses Document date: 2016_11_17
ID: 096348l5_17
Snippet: Kidney, spleen, and liver tissues were collected from animals treated with 14 daily doses of 10 mg/kg of GRFT, on the last treatment day (Day 14) or after a week recovery (Day 21) and fixed in 10% neutral buffered formalin. Paraffin-embedded sections were stained with hematoxylin and eosin (H and E staining) and evaluated in a blinded manner by a trained pathologist......
Document: Kidney, spleen, and liver tissues were collected from animals treated with 14 daily doses of 10 mg/kg of GRFT, on the last treatment day (Day 14) or after a week recovery (Day 21) and fixed in 10% neutral buffered formalin. Paraffin-embedded sections were stained with hematoxylin and eosin (H and E staining) and evaluated in a blinded manner by a trained pathologist.
Search related documents:
Co phrase search for related documents- daily dose and mg GRFT kg: 1
- daily dose and treatment day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- GRFT kg and mg GRFT kg: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- GRFT kg and treatment day: 1, 2, 3, 4
- GRFT kg and week recovery: 1, 2, 3
- liver tissue and treatment day: 1
- mg GRFT kg and treatment day: 1, 2, 3, 4
- mg GRFT kg and week recovery: 1, 2, 3
- treatment day and week recovery: 1, 2
Co phrase search for related documents, hyperlinks ordered by date